| Name | proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) |
| Description | The protein encoded by this gene is the predominant constituent of the crystalline core of the eosinophil granule. High levels of the proform of this protein are also present in placenta and pregnancy serum, where it exists as a complex with several other proteins including pregnancy-associated plasma protein A (PAPPA), angiotensinogen (AGT), and C3dg. This protein may be involved in antiparasitic defense mechanisms as a cytotoxin and helminthotoxin, and in immune hypersensitivity reactions. The encoded protein contains a peptide that displays potent antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria, and fungi. It is directly implicated in epithelial cell damage, exfoliation, and bronchospasm in allergic diseases. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2014] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nEosinophil PRG2—the gene encoding the prototypical eosinophil granule major basic protein (MBP)—is subject to precise transcriptional regulation during eosinophil differentiation. For example, studies have shown that lineage‐specific transcription factors such as GATA‑1 and PU.1 act in concert to transactivate the MBP gene, whereas certain isoforms of C/EBPε serve as potent repressors, thereby establishing a tightly controlled program for MBP expression in developing eosinophils."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond transcriptional control, PRG2 product function is modulated through its interactions with other proteins. Several investigations have demonstrated that MBP (or its proform, proMBP) forms covalent complexes with the metalloproteinase PAPP‑A—complex formation that involves specific disulfide bonding—and thereby serves as an inhibitor regulating IGF bioavailability. This regulatory complex, which is highly relevant in reproductive biology and acute coronary syndromes, is mapped to distinct short consensus repeats in PAPP‑A and is sensitive to redox conditions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "2", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIntracellularly, PRG2 product is packaged into the crystalloid cores of eosinophil granules in a highly ordered nanocrystalline form that restrains its innate toxicity. Upon appropriate stimulation, eosinophils mobilize MBP via vesicular transport (piecemeal degranulation) so that both granule‐stored and vesicle‐associated pools are available for secretion; such regulated release mechanisms are crucial for ensuring that extracellular MBP exerts its biological functions only under tightly controlled conditions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nOnce secreted, MBP performs key cytotoxic and immunomodulatory functions. It can directly trigger the activation of neutrophils through signaling cascades involving PI3‑kinase, Akt and atypical PKC, and also stimulate mast cells in the context of allergic cross‐talk. In respiratory epithelia, MBP synergizes with pathogens (e.g. respiratory syncytial virus) to provoke cell death and the release of pro‐inflammatory cytokines, while in other tissues MBP contributes to local tissue damage and remodeling in conditions such as eosinophilic myositis, atopic cataracts and chronic rhinosinusitis. Moreover, MBP binding to cell‐surface heparan sulfate proteoglycans via discrete surface‐exposed residues further suggests its role as an intercellular signal modulator in inflammatory settings."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its classical effector roles in allergic inflammation, emerging evidence indicates that PRG2 expression may also function as a biomarker and exert tumor‐suppressive effects in certain contexts. For instance, in imatinib‐resistant chronic myeloproliferative cells, forced PRG2 overexpression (along with associated hypomethylation) has been linked to inactivation of STAT3 and enhanced sensitivity to the drug, suggesting a potential tumor suppressor role. Similarly, alterations in circulating proMBP levels have been observed in hematologic disorders."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "24"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, in the context of obstetrics, upregulated and mislocalized PRG2 expression in extraembryonic tissues—including the fetal membranes and placental disk—has been associated with conditions of abnormal trophoblast invasion such as placenta previa and placenta accreta spectrum, implying that PRG2 may serve as a marker for increased invasiveness in these pathologies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jian Du, Monika J Stankiewicz, Yang Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M204777200"}], "href": "https://doi.org/10.1074/jbc.M204777200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12202480"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12202480"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Lisbeth S Laursen, Michael T Overgaard, Kathrin Weyer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cell surface targeting of pregnancy-associated plasma protein A proteolytic activity. Reversible adhesion is mediated by two neighboring short consensus repeats."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M209155200"}], "href": "https://doi.org/10.1074/jbc.M209155200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12370176"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12370176"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Michael T Overgaard, Esben S Sorensen, Damian Stachowiak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Complex of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein. Disulfide structure and carbohydrate attachment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M208777200"}], "href": "https://doi.org/10.1074/jbc.M208777200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12421832"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12421832"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Michael T Overgaard, Simon Glerup, Henning B Boldt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of proteolysis by the proform of eosinophil major basic protein (proMBP) requires covalent binding to its target proteinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S0014-5793(04)00095-X"}], "href": "https://doi.org/10.1016/S0014-5793(04"}, {"type": "t", "text": "00095-X) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14988014"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14988014"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Simon Glerup, Henning B Boldt, Michael T Overgaard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Proteinase inhibition by proform of eosinophil major basic protein (pro-MBP) is a multistep process of intra- and intermolecular disulfide rearrangements."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M413228200"}], "href": "https://doi.org/10.1074/jbc.M413228200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15647258"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15647258"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "P Hájek, M Macek, M Hladíková, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pregnancy-associated plasma protein A and proform eosinophilic major basic protein in the detection of different types of coronary artery disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Physiol Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.33549/physiolres.930986"}], "href": "https://doi.org/10.33549/physiolres.930986"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17223728"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17223728"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Søren Kløverpris, Louise L Skov, Simon Glerup, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Formation of high-molecular-weight angiotensinogen during pregnancy is a result of competing redox reactions with the proform of eosinophil major basic protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20120801"}], "href": "https://doi.org/10.1042/BJ20120801"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23033876"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23033876"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Jing Hou, Bing Zhou, Luo Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Expression and its significance of eosinophil major basic protein in chronic rhinosinusitis]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2008)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18720885"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18720885"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Rossana C N Melo, Lisa A Spencer, Sandra A C Perez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vesicle-mediated secretion of human eosinophil granule-derived major basic protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lab Invest (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/labinvest.2009.40"}], "href": "https://doi.org/10.1038/labinvest.2009.40"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19398958"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19398958"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Alice Soragni, Shida Yousefi, Christina Stoeckle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Toxicity of eosinophil MBP is repressed by intracellular crystallization and promoted by extracellular aggregation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2015.01.026"}], "href": "https://doi.org/10.1016/j.molcel.2015.01.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25728769"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25728769"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Diane L Squillace, James L Checkel, Ayalew Tefferi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Development and application of novel immunoassays for eosinophil granule major basic proteins to evaluate eosinophilia and myeloproliferative disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol Methods (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jim.2021.113015"}], "href": "https://doi.org/10.1016/j.jim.2021.113015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33689807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33689807"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "K Murata, K Sugie, M Takamure, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Eosinophilic major basic protein and interleukin-5 in eosinophilic myositis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Neurol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1468-1331.2003.00481.x"}], "href": "https://doi.org/10.1046/j.1468-1331.2003.00481.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12534990"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12534990"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Neeta G Shenoy, Gerald J Gleich, Larry L Thomas "}, {"type": "b", "children": [{"type": "t", "text": "Eosinophil major basic protein stimulates neutrophil superoxide production by a class IA phosphoinositide 3-kinase and protein kinase C-zeta-dependent pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.171.7.3734"}], "href": "https://doi.org/10.4049/jimmunol.171.7.3734"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14500673"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14500673"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Simon Glerup, Søren Kløverpris, Claus Oxvig "}, {"type": "b", "children": [{"type": "t", "text": "The proform of the eosinophil major basic protein binds the cell surface through a site distinct from its C-type lectin ligand-binding region."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M605824200"}], "href": "https://doi.org/10.1074/jbc.M605824200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16940047"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16940047"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Chun Zhang, Yiming Jiang, Jie Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Expression of eosinophil major basic protein and neutrophil elastase in nasal polyp tissue and secretion]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2008)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18476621"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18476621"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Taisei Ishioka, Hirokazu Kimura, Hirohito Kita, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Int (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/CBI20100255"}], "href": "https://doi.org/10.1042/CBI20100255"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20977431"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20977431"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "M Ben-Zimra, I Bachelet, M Seaf, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Eosinophil major basic protein activates human cord blood mast cells primed with fibroblast membranes by integrin-β1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Allergy (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/all.12232"}], "href": "https://doi.org/10.1111/all.12232"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24112102"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24112102"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jae-Woo Jung, Hye-Ryun Kang, Hyun-Seung Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression levels of eosinophil granule protein mRNAs in induced sputum reflect airway hyperresponsiveness and airflow limitation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tohoku J Exp Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1620/tjem.233.49"}], "href": "https://doi.org/10.1620/tjem.233.49"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24814827"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24814827"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jens U Ponikau, Laurie A Winter, Gail M Kephart, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An immunologic test for chronic rhinosinusitis based on free intranasal eosinophilic major basic protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Forum Allergy Rhinol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/alr.21421"}], "href": "https://doi.org/10.1002/alr.21421"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25266917"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25266917"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Naoki Yamamoto, Noriko Hiramatsu, Sumito Isogai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mechanism of atopic cataract caused by eosinophil granule major basic protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Mol Morphol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00795-019-00234-5"}], "href": "https://doi.org/10.1007/s00795-019-00234-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31595373"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31595373"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Douglas A Plager, David A Loegering, James L Checkel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Major basic protein homolog (MBP2): a specific human eosinophil marker."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.177.10.7340"}], "href": "https://doi.org/10.4049/jimmunol.177.10.7340"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17082653"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17082653"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Qumar Parwez, Susanne Stemmler, Jörg T Epplen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Variation in genes encoding eosinophil granule proteins in atopic dermatitis patients from Germany."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Negat Results Biomed (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1477-5751-7-9"}], "href": "https://doi.org/10.1186/1477-5751-7-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19014520"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19014520"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Ching-Liang Ho, Hirohito Kito, Diane L Squillace, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical correlates of serum pro-major basic protein in a spectrum of eosinophilic disorders and myelofibrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Haematol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000178148"}], "href": "https://doi.org/10.1159/000178148"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19039208"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19039208"}]}, {"type": "r", "ref": 24, "children": [{"type": "p", "children": [{"type": "t", "text": "Hamid Ali Nagi Al-Jamal, Muhammad Farid Johan, Siti Asmaa Mat Jusoh, et al. **Re-Expression of Bone Marrow Proteoglycan-2 by 5-Azacytidine is associated with STAT3 Inactivation and Sensitivity"}]}, {"type": "t", "text": "Response to Imatinib in Resistant CML Cells"}, {"type": "i", "children": [{"type": "i", "children": [{"type": "t", "text": " "}]}, {"type": "t", "text": "Asian Pac J Cancer Prev (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.22034/APJCP.2018.19.6.1585"}], "href": "https://doi.org/10.22034/APJCP.2018.19.6.1585"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29936783"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29936783"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Elisa T Zhang, Roberta L Hannibal, Keyla M Badillo Rivera, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PRG2 and AQPEP are misexpressed in fetal membranes in placenta previa and percreta†."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Reprod (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/biolre/ioab068"}], "href": "https://doi.org/10.1093/biolre/ioab068"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33982062"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33982062"}]}]}]}
|
| Synonyms | BMPG, proMBP |
| Proteins | PRG2_HUMAN |
| NCBI Gene ID | 5553 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PRG2 has 7,574 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 108 datasets.
Click the + buttons to view associations for PRG2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by PRG2 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PRG2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PRG2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PRG2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PRG2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PRG2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PRG2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PRG2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of PRG2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRG2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PRG2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with PRG2 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with PRG2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PRG2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of PRG2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PRG2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PRG2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PRG2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PRG2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing PRG2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PRG2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PRG2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRG2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with PRG2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with PRG2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with PRG2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by PRG2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with PRG2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PRG2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PRG2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with PRG2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with PRG2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for PRG2 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PRG2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PRG2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of PRG2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PRG2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PRG2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with PRG2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PRG2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PRG2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PRG2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PRG2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PRG2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PRG2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PRG2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding PRG2 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving PRG2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving PRG2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing PRG2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing PRG2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by PRG2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PRG2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PRG2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PRG2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with PRG2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with PRG2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with PRG2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PRG2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for PRG2 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PRG2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of PRG2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of PRG2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PRG2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for PRG2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with PRG2 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PRG2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by PRG2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for PRG2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PRG2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PRG2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PRG2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving PRG2 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRG2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PRG2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PRG2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PRG2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of PRG2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PRG2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PRG2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PRG2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PRG2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of PRG2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by PRG2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PRG2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NURSA Protein Complexes | protein complexs containing PRG2 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for PRG2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PRG2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PRG2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving PRG2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving PRG2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving PRG2 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PRG2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PRG2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PRG2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PRG2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PRG2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of PRG2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of PRG2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PRG2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PRG2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PRG2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PRG2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PRG2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PRG2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PRG2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PRG2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PRG2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |